Maximo F. Nougues, Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 10,945 shares at $5.84 ($64K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Scheduled sale ($64k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.84 | 4,540 | $27K | 41.3% |
| 2 | $5.88 | 6,405 | $38K | 58.7% |
| Total | $5.86 avg | 10,945 | $64K | 100% |
| Filing → |
| PBYI | SELL | 2025-01-03 | $32K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $15K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $17K | — | Filing → |